In this digital transformation race sprung about by COVID-19, companies like IMAPAC have rapidly increased the use of digital tools to stay afloat during the pandemic. Revamping from having a portfolio that consisted… read more

INFOGRAPHIC OF THE WEEK In a recent market outlook analysis by Genetic Engineering & Biotechnology News, the APAC global cell and gene therapy space has been predicted to emerge as a major market.… read more

IMAPAC recently rounded up its “Corona360 In-Conversation” series of live moderated interviews. It brought together vaccine industry experts in lively, thought-provoking discussions on the challenges and possible solutions in the race to develop… read more

Novartis secures licenses to Mesoblast’s Cell Therapy for treatment of COVID-19 Novartis has recently secured a global license to Mesoblast’s cell therapy remestemcel-L in the treatment of COVID-19. Under the terms of the… read more

Oxford and AstraZeneca’s COVID-19 vaccine candidate shows 90% efficacy in clinical trials.  The late-stage human trials for the COVID-19 vaccine candidate developed by Oxford University and AstraZeneca showed that the vaccine could be… read more

Y-Biologics And Pierre Fabre Form A Strategic Partnership For The Development Of Monoclonal Antibodies. Y-Biologics, a South Korean Biotech, and Pierre Fabre, a French pharmaceutical group have recently announced their strategic partnership of… read more

Brainstorm Therapeutics’ Stem Cell Therapy for ALS Fails to Meet Expected Results.  Brainstorm Therapeutics recently revealed that its experimental treatment for ALS did not meet the main goal of a late-stage clinical trial,… read more

Pfizer-BioNTech COVID-19 vaccine could potentially be available by December.  Pfizer and BioNTech could secure emergency US Food and Drug Administration and European authorization for their COVID-19 vaccine in December after final trial results… read more

Eli Lilly partners with Samsung Biologics to improve COVID-19 antibody manufacturing efforts. Eli Lilly recently announced that it would be partnering with Samsung Biologics to accelerate the manufacturing of its COVID-19 antibodies. The… read more

Download their Whitepaper here When a clinical trial organisation was looking to set up a new trial with the aim of servicing children and young adults who have a particular chronic condition, they… read more

LIfT BioSciences’ N-LIfT Cell Therapy Successfully Infiltrates Pancreatic Tumours. LIfT BioSciences has successfully demonstrated migration to the human pancreatic tumor site in a mice model using its cell therapy, N-LIfT.   The tumor was… read more

Merck & Co. partners with Volansi to test deliver cold chain products straight from manufacturing facility to a health clinic. Merck is testing using Volansi’s VOLY C10 drone to deliver vaccines and medicinal… read more

Thermo Fisher Scientific and Innoforce signs a joint venture agreement.  Thermo Fisher Scientific and Innoforce recently announced that they have signed a joint venture agreement to establish a new pharmaceutical service facility in… read more